Tod Klingler

Biography
Tod Klingler, PhD, is a visionary leader in genomics and personalized healthcare with deep expertise in machine learning, molecular diagnostics, and big data analytics. With a proven track record of founding and scaling successful start-ups, he has developed cutting-edge solutions that advance precision medicine. His leadership has driven innovations in genomics testing, personalized health programs, and data-driven healthcare platforms. As an experienced product strategist, Tod excels at integrating advanced medical technologies to enhance disease prevention, precise diagnostics, and treatment optimization, making a significant impact on healthcare outcomes worldwide.

---

Talk
Leveraging Genomics and AI to Personalize Drug Therapy
This talk will describe how GeneLeap's innovative platform combines generative AI structure prediction advancements combined with an individual's genetics to optimize drug therapies. By predicting drug response, side effects and metabolic interactions, this technology promises to provide tailored treatment recommendation and mitigate therapeutic odysseys.

Pharmacogenomics Showcase:
GeneLeap
GeneLeap is developing a generative AI-based platform to optimize drug therapies for individuals with depression. The platform will generate treatment recommendations using an individual's genetic makeup with the goal of improving treatment outcomes by reducing the trial-and-error process often encountered in psychiatric care.